THE VISION

Bioregulators represent one of the most underexplored frontiers in human health with the potential to influence repair, adaptation, and resilience at the molecular level.

Our approach is to investigate these molecules with scientific depth and long-term thinking: to better understand how biology regulates itself and how that understanding could change lives.

Our Vision

A world where health is proactive, not reactive.
Where biology isn’t suppressed, it’s supported.
Where aging is understood, not feared.
Where we stop managing symptoms and start understanding systems.

Our perspective is clear: health advances when we understand and work with the body’s internal design.

We’re building a new pathway for biological resilience.

Built on biology. Driven by discovery. Defined by purpose.

Our Team

We are scientists, engineers, innovators with a shared belief: the current model of health is due for reinvention. Our team combines deep scientific expertise with a willingness to challenge assumptions in pursuit of better answers.

We operate at the intersection of biology, technology, and systems thinking.

With backgrounds spanning molecular biology, entrepreneurship, bioinformatics, and drug development, we are focused on solving problems that matter and building tools that last. This is early-stage science with long-term intent. We’re here to lead the next chapter in bioregulatory research.

Jordan Owyoung, PhD

Founding Scientist, Biology

Rick Karr

Founder & CEO

David Yue, Ph.D.
Founding Scientist, Chemistry

Our Values

Scientific Rigor

We pursue evidence. Every insight is built on methodical research and disciplined inquiry.

Clarity Through Simplicity

Complexity doesn’t intimidate us, but we believe great science should be accessible, not obscured.

Collaboration with Purpose

We seek out partners who share our standards and want to move science forward, not just through ambition, but through intention.

Transparency by Default

We’re honest about where we are, what we know, and what we’re still investigating. Integrity drives progress.

Jordan Owyoung, PhD

Founding Scientist

“Geneticist and Strategist – building therapies and chasing sunshine.”

Jordan went to undergrad at UC Davis and earned her PhD in Genetics and Molecular Biology from Emory University. Her research focused on the role of the sympathetic nervous system in skeletal muscle health. She brings a unique blend of scientific expertise, entrepreneurial drive, and biotech consulting experience, having worked with early-stage companies to advance technologies. Jordan is passionate about bridging scientific innovation and business, with a particular focus on novel therapeutics.

Outside the lab, Jordan embraces the San Diego lifestyle—whether that’s hiking the coastal trails, beachfront yoga, or attempting to surf (current record: five waves successfully caught and counting).

Rick Karr

Founder & CEO

Builder & Strategist — turning research into reality.

Rick Karr leads BioRegs with a clear mission: advance preventive, regenerative therapeutics through rigor and disciplined execution. He turns complex problems into clean systems—standing up quality processes, coordinating the right partners, and building teams that move promising science toward scalable reality.

A serial entrepreneur, Rick brings an operator’s lens to strategy, supply chains, and compliance-first practices that create long-term value without the fluff. Prior to BioRegs, he founded independent ventures in regenerative health, applying the same rigor to growth and delivery.

Off the clock, it’s family first — surf, golf, and a little moto therapy.

David Yue, Ph.D.

Founding Scientist, Chemistry

Dawei (David) Yue, Ph.D. is an accomplished executive and medicinal chemist with over 20 years of leadership in drug discovery, analytical chemistry, and biotechnology innovation.

He currently serves as President and CEO of AxisPharm, where he has expanded capabilities through strategic acquisitions and built advanced analytical platforms to serve the biotech community. Dr. Yue’s career includes senior roles at BroadPharm, Crown Biosciences, and Arena Pharmaceuticals, where he directed oncology, metabolic, and inflammatory disease programs from hit identification to candidate selection.

He holds a Ph.D. in Organic Chemistry from Iowa State University and has authored multiple patents and publications, underscoring his track record of scientific and business leadership.